Evidence map›Paper›PMID 34179126›Full record

ReviewFrontiers in cardiovascular medicine2021

Current Devices and Complications Related to Transcatheter Mitral Valve Replacement: The Bumpy Road to the Top.

Faraj Kargoli, Matteo Pagnesi, Kusha Rahgozar, Ythan Goldberg, Edwin Ho, Mei Chau, Antonio Colombo, Azeem Latib

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Faraj KargoliDepartment of Cardiology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States.
Matteo PagnesiCardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.
Kusha RahgozarDepartment of Internal Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States.
Ythan GoldbergDepartment of Cardiology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States.
Edwin HoDepartment of Cardiology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States.
Mei ChauDepartment of Cardiothoracic Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States.
Antonio ColomboInterventional Cardiology Unit, GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy.
Azeem LatibDepartment of Cardiology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States.
Montefiore Medical Center · USAlbert Einstein College of Medicine · USMaria Cecilia Hospital · ITSan Raffaele University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitral regurgitation is the most common valvular lesion in the developed world, with increasing prevalence, morbidity, and mortality. The experience with surgical mitral valve repair or replacement is very well-validated. However, more than 45% of these patients get denied surgery due to an elevated risk profile and advanced disease of the left ventricle at the time of presentation, promoting the need for less invasive transcatheter options such as transcatheter repair and transcatheter mitral valve replacement (TMVR). Early available TMVR studies have shown promising results, and several dedicated devices are under clinical evaluation. However, TMVR is still in the early developmental stages and is associated with a non-negligible risk of periprocedural and post-procedural complications. In this review, we discuss the current challenges facing TMVR and the potential TMVR-related complications, offering an overview on the measures implemented to mitigate these complications, and future implications.

Indexed as

lvot obstructionTMVRTMVR complicationsvalve embolizationvalve thrombosis

Identifiers

PMID34179126
PMCPMC8230552
OpenAlexW3171837368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.